Shenkman Capital Management »

Bridgebio Pharma shares owned by Shenkman Capital Management

Quarter-by-quarter ownership of Bridgebio Pharma shares owned by Shenkman Capital Management from 13F filings

Historical chart of Shenkman Capital Management investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Shenkman Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Shenkman Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $6.8B 6.7M 1012.92

More positions owned by Shenkman Capital Management

Etsy Note 0.250% 6/1 (Principal)
Uniti Group Note 7.500%12/0 (Principal)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)
Duke Energy Corp Note 4.125% 4/1 (Principal)
Snap Note 0.500% 5/0 (Principal)
Southern Note 4.500% 6/1 (Principal)
Cms Energy Corp Note 3.375% 5/0 (Principal)
Global Pmts Note 1.500% 3/0 (Principal)
Varonis Sys Note 1.000% 9/1 (Principal)
Digitalocean Hldgs Note 12/0 (Principal)
Firstenergy Corp Note 4.000% 5/0 (Principal)
Guardant Health Debt 1.250% 2/1 (Principal)
Dropbox Note 3/0 (Principal)
Microchip Technology Note 0.750% 6/0 (Principal)
Super Micro Computer Note 3.500% 3/0 (Principal)

View all positions for Shenkman Capital Management

Top funds holding Bridgebio Pharma

Linden Advisors
Wolverine Asset Management
Camden Asset Management
Sona Asset Management
Ing Investment Management
Steelhead Partners
Davidson Kempner Capital Management
MacKay Shields
D. E. Shaw & Co
Jump Financial
Wells Fargo & Company
Advent Capital Management
Laurion Capital Management
State Street Corporation
Lazard Asset Management

View all funds holding Bridgebio Pharma